Net profit of Medico Remedies rose 9.54% to Rs 2.87 crore in the quarter ended December 2025 as against Rs 2.62 crore during the previous quarter ended December 2024. Sales rose 48.59% to Rs 58.68 crore in the quarter ended December 2025 as against Rs 39.49 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales58.6839.49 49 OPM %7.387.88 - PBDT4.624.26 8 PBT3.833.50 9 NP2.872.62 10 Powered by Capital Market - Live News

Medico Remedies will hold a meeting of the Board of Directors of the Company on 12 February 2026.Powered by Capital Market - Live News

Net profit of Medico Remedies rose 65.81% to Rs 2.57 crore in the quarter ended September 2025 as against Rs 1.55 crore during the previous quarter ended September 2024. Sales rose 33.77% to Rs 52.64 crore in the quarter ended September 2025 as against Rs 39.35 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales52.6439.35 34 OPM %5.176.12 - PBDT4.202.88 46 PBT3.472.13 63 NP2.571.55 66 Powered by Capital Market - Live News

Medico Remedies will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live News

Medico Remedies has secured government supply order for USD 1,116,517 to supply to PROMESE/CAL, Dominican Republic. PROMESE/CAL (Programa de Medicamentos Esenciales y Central de Log�stica) is the program responsible for the centralized purchase and distribution of medicines, health supplies and laboratory reagents that meets the demand of the National Public Health System in the Country of Dominican Republic. Medico Remedies has secured the order to supply tablets, capsules and dry syrups to PROMESE/CAL and will complete the supply of the full order within 3 months. Powered by Capital Market - Live News